Dutch probiotics supplier, Winclove Bio Industries, has pulled its entire range of 30 health claim submissions from the European Union health claims process, in fear of the business impact of negative opinions from the claims assessor, EFSA.
Japanese probiotics pioneer, Yakult Honsha, will commence manufacturing its little probiotic dairy bottles in the US for the first time in 2012, the company has announced, as it seeks to move into eastern seaboard US states.
Swedish probiotics player, Probi, is pursuing “unofficial” dialogue with the European Food Safety Authority (EFSA) after the scientific agency closed the formal process by rejecting its probiotic health claim appeal.
Beverage manufacturers seeking to extend their health and wellness portfolio can now incorporate a clinical dose of an immune boosting probiotic strain to their refrigerated fruit juice range while keeping their all-natural positioning, claims Danisco.
A dossier containing 13 randomised controlled trials, 6 observational studies, and 15 non-human studies has failed to impress European Food Safety Authority (EFSA) scientists because the four strains in question were not sufficiently characterised.
Probiotics should be considered as living drugs rather than “simple good bacteria” in order to become effective treatment options for IBS, according to Joseph Haddad, medical director of Institut Rosell-Lallemand.
As a raft of non-positive opinions on probiotics floats down the health claims river, questions have been asked of the efficacy of the beneficial bacteria. Two experts discuss where we stand and how to get the good ship Probiotic back on course.
Three of Europe’s largest food supplement and healthy product trade groups have issued a 17-page paper that lays out its many concerns with the scientific approach being taken by EFSA in regard to health claims.